AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36285519 — intervention group
Group type: EXPERIMENTAL
Intervention: Dalpiciclib 100 mg
Number of subjects: 36
Study 36285519 — intervention group
Group type: EXPERIMENTAL
Intervention: Dalpiciclib 125 mg
Number of subjects: 36
Study 36285519 — intervention group
Group type: EXPERIMENTAL
Intervention: Dalpiciclib 150 mg
Number of subjects: 36
Study 34161466 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous mitral balloon valvuloplasty
Number of subjects: 527
Study 34161466 — intervention group
Group type: COMPARATOR
Intervention: Mitral valve replacement
Number of subjects: 527
Study 32744385 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 infusion
Number of subjects: 8
Study 34878502 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 9718
Study 34878502 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9718
Study 33710347 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment as usual with additional differential treatment component
Number of subjects: 219
Study 33066869 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylcobalamin (500 mcg/day)
Number of subjects: 80
Study 33066869 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid (5 mg/day) + Methylcobalamin (500 mcg/day)
Number of subjects: 80
Study 33066869 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid (5 mg/day)
Number of subjects: 80
Study 33066869 — intervention group
Group type: COMPARATOR
Intervention: Standard oral anti-diabetic drugs
Number of subjects: 80
Study 35533490 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold therapy applied before deep breathing and coughing exercises
Number of subjects: 70
Study 35533490 — intervention group
Group type: COMPARATOR
Intervention: Control group (no cold therapy)
Number of subjects: 70
Study 32991994 — intervention group
Group type: EXPERIMENTAL
Intervention: Seamless designs in diagnostic research
Number of subjects: 0
Study 32991994 — intervention group
Group type: EXPERIMENTAL
Intervention: Accuracy studies
Number of subjects: 0
Study 32991994 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized diagnostic studies
Number of subjects: 0
Study 32991994 — intervention group
Group type: EXPERIMENTAL
Intervention: Change-in-management studies
Number of subjects: 0
Study 32479544 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle (LS) programme with CBT, healthy diet, and physical therapy
Number of subjects: 155
Study 32479544 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle (LS) programme without SMS
Number of subjects: 155
Study 32479544 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle (LS) programme with SMS
Number of subjects: 155
Study 32479544 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle (LS) programme
Number of subjects: 155
Study 32479544 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (CAU)
Number of subjects: 155
Study 36371903 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 440
Study 36371903 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural Activation (BA)
Number of subjects: 440
Study 32448934 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurses
Number of subjects: 209
Study 32448934 — intervention group
Group type: COMPARATOR
Intervention: Nursing students
Number of subjects: 209
Study 33109859 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 1 μg/kg/h
Number of subjects: 24
Study 33109859 — intervention group
Group type: COMPARATOR
Intervention: Dexmedetomidine 0.5 μg/kg/h
Number of subjects: 24
Study 36362704 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive therapy (intermittent use of a very strong topical corticosteroid for 4 weeks)
Number of subjects: 49
Study 36362704 — intervention group
Group type: COMPARATOR
Intervention: Rank-down therapy (daily use of a strong topical corticosteroid for 1 week followed by daily use of a medium-potency topical corticosteroid for 3 weeks)
Number of subjects: 49
Study 36362704 — intervention group
Group type: COMPARATOR
Intervention: Rank-down therapy
Number of subjects: 49
Study 36362704 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive therapy
Number of subjects: 49
Study 33011188 — intervention group
Group type: EXPERIMENTAL
Intervention: Explicit learning of different types of linguistic information of artificial words (phonological, phonological + semantic, or phonological + orthographic information)
Number of subjects: 0
Study 33011188 — intervention group
Group type: COMPARATOR
Intervention: Control group (no explicit learning of words)
Number of subjects: 0
Study 34788453 — intervention group
Group type: EXPERIMENTAL
Intervention: Black participants
Number of subjects: 196
Study 34788453 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19 impact
Number of subjects: 196
Study 34788453 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19 related stress
Number of subjects: 196
Study 33388052 — intervention group
Group type: EXPERIMENTAL
Intervention: Understanding of informed consent for randomized clinical trials in emergency obstetric and newborn care.
Number of subjects: 18
Study 33388052 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceptions of the necessity of research in emergency obstetric and newborn care.
Number of subjects: 18
Study 33388052 — intervention group
Group type: EXPERIMENTAL
Intervention: Influence of emergency contexts on understanding research information.
Number of subjects: 18
Study 33388052 — intervention group
Group type: EXPERIMENTAL
Intervention: Concerns regarding risks to unborn babies or newborns.
Number of subjects: 18
Study 33388052 — intervention group
Group type: EXPERIMENTAL
Intervention: Influence of solidarity on decision-making.
Number of subjects: 18
Study 33314790 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozanimod and its major active metabolites (CC112273 and CC1084037)
Number of subjects: 0
Study 33314790 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33017662 — intervention group
Group type: EXPERIMENTAL
Intervention: Transplanted patients (both arms)
Number of subjects: 367
Study 33017662 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with last recorded response of CRc before allo-HSCT (both arms)
Number of subjects: 367
Study 33017662 — intervention group
Group type: EXPERIMENTAL
Intervention: Quizartinib (post-allo-HSCT)
Number of subjects: 367
Study 33017662 — intervention group
Group type: COMPARATOR
Intervention: Salvage chemotherapy (post-allo-HSCT)
Number of subjects: 367
Study 33136142 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (a-tDCS)
Number of subjects: 2
Study 33136142 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal transcranial direct current stimulation (c-tDCS)
Number of subjects: 2
Study 33136142 — intervention group
Group type: COMPARATOR
Intervention: Sham transcranial direct current stimulation
Number of subjects: 2
Study 32475457 — intervention group
Group type: EXPERIMENTAL
Intervention: Ca‐deficient diet (0.35% Ca + 0.45% NPP)
Number of subjects: 504
Study 32475457 — intervention group
Group type: EXPERIMENTAL
Intervention: P‐deficient diet (1.00% Ca + 0.23% NPP)
Number of subjects: 504
Study 32475457 — intervention group
Group type: EXPERIMENTAL
Intervention: Ca- and P-deficient diet (0.35% Ca + 0.23% NPP)
Number of subjects: 504
Study 32475457 — intervention group
Group type: COMPARATOR
Intervention: Ca- and P-adequate diet (1.00% Ca + 0.45% NPP)
Number of subjects: 504
Study 34197135 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis risk reduction intervention
Number of subjects: 225
Study 32950254 — intervention group
Group type: EXPERIMENTAL
Intervention: TRIOS 3 (TR)
Number of subjects: 20
Study 32950254 — intervention group
Group type: EXPERIMENTAL
Intervention: CEREC Omnicam (OC)
Number of subjects: 20
Study 32950254 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete-crown scan
Number of subjects: 20
Study 32950254 — intervention group
Group type: COMPARATOR
Intervention: Both scanners
Number of subjects: 20
Study 32950254 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete-arch scans
Number of subjects: 20
Study 36045468 — intervention group
Group type: EXPERIMENTAL
Intervention: Essential oils mouthwash
Number of subjects: 180
Study 36045468 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of essential oils and 0.12% chlorhexidine mouthwash
Number of subjects: 180
Study 36045468 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogen peroxide (0.8%) mouthwash
Number of subjects: 180
Study 36045468 — intervention group
Group type: EXPERIMENTAL
Intervention: Prebiotic mouthwash
Number of subjects: 180
Study 36045468 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine mouthwash
Number of subjects: 180
Study 36045468 — intervention group
Group type: COMPARATOR
Intervention: Placebo mouthwash
Number of subjects: 180
Study 35399802 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 140
Study 35399802 — intervention group
Group type: COMPARATOR
Intervention: Insulin
Number of subjects: 140
Study 34018671 — intervention group
Group type: EXPERIMENTAL
Intervention: Gracey curettes-Hu-Friedy®
Number of subjects: 17
Study 34018671 — intervention group
Group type: EXPERIMENTAL
Intervention: Piezoelectric ultrasonic (Satelec®)
Number of subjects: 17
Study 34018671 — intervention group
Group type: EXPERIMENTAL
Intervention: Piezosurgery ultrasonic (Mectron®)
Number of subjects: 17
Study 34018671 — intervention group
Group type: COMPARATOR
Intervention: Diamond burs 40µm (Intensiv Perioset®)
Number of subjects: 17
Study 34018671 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 17
Study 32585686 — intervention group
Group type: EXPERIMENTAL
Intervention: Gonadotropins
Number of subjects: 666
Study 32585686 — intervention group
Group type: COMPARATOR
Intervention: Clomiphene citrate (CC)
Number of subjects: 666
Study 35483297 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular acupressure (AurPrs)
Number of subjects: 56
Study 35483297 — intervention group
Group type: COMPARATOR
Intervention: Sham AurPrs treatment
Number of subjects: 56
Study 33875811 — intervention group
Group type: EXPERIMENTAL
Intervention: Stoss therapy (single high-dose oral vitamin D therapy) plus weekly/daily supplementation
Number of subjects: 48
Study 33875811 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (per US Endocrine Society guidelines)
Number of subjects: 48
Study 35871441 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic stapedotomy (n = 44)
Number of subjects: 88
Study 35871441 — intervention group
Group type: COMPARATOR
Intervention: Microscopic stapedotomy (n = 44)
Number of subjects: 88
Study 33517725 — intervention group
Group type: EXPERIMENTAL
Intervention: Cast immobilization
Number of subjects: 100
Study 33517725 — intervention group
Group type: COMPARATOR
Intervention: Volar locking plate operation
Number of subjects: 100
Study 32663945 — intervention group
Group type: EXPERIMENTAL
Intervention: Deceptive active placebo via intranasal application with expectancy-enhancing instructions
Number of subjects: 91
Study 32663945 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 91
Study 32308130 — intervention group
Group type: EXPERIMENTAL
Intervention: VIPP‐SD intervention (Nintervention = 40)
Number of subjects: 68
Study 32308130 — intervention group
Group type: COMPARATOR
Intervention: Control group (Ncontrol = 28)
Number of subjects: 68
Study 32303737 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide (TAC) injections (10 mg/ml), with up to three injections administered over 12 weeks (initial injection, followed by two additional injections 6 weeks apart).
Number of subjects: 50
Study 32303737 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving usual care for hypertrophic scars.
Number of subjects: 50
Study 32303737 — intervention group
Group type: EXPERIMENTAL
Intervention: TAC injections (10 mg/ml).
Number of subjects: 50
Study 33529794 — intervention group
Group type: EXPERIMENTAL
Intervention: Trabecular bypass shunts
Number of subjects: 0
Study 33529794 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser-based cyclodestruction procedures
Number of subjects: 0
Study 33529794 — intervention group
Group type: COMPARATOR
Intervention: Trabeculectomies
Number of subjects: 0
Study 33529794 — intervention group
Group type: COMPARATOR
Intervention: Traditional glaucoma surgeries
Number of subjects: 0
Study 33529794 — intervention group
Group type: COMPARATOR
Intervention: Physician payment data
Number of subjects: 0
Study 35246380 — intervention group
Group type: EXPERIMENTAL
Intervention: Lean intervention (relocating the printer to the front desk)
Number of subjects: 40
Study 35246380 — intervention group
Group type: EXPERIMENTAL
Intervention: Lean intervention (adding another parallel working station)
Number of subjects: 40
Study 35246380 — intervention group
Group type: EXPERIMENTAL
Intervention: Lean intervention (documenting in plain typing)
Number of subjects: 40
Study 35246380 — intervention group
Group type: EXPERIMENTAL
Intervention: Lean intervention (rerouting delayed patients to the next available physician)
Number of subjects: 40
Study 35246380 — intervention group
Group type: EXPERIMENTAL
Intervention: Lean intervention
Number of subjects: 40
Study 35246380 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 33461484 — intervention group
Group type: EXPERIMENTAL
Intervention: Electromagnetic guidance ultrasound system
Number of subjects: 76
Study 33461484 — intervention group
Group type: COMPARATOR
Intervention: Conventional ultrasound guidance
Number of subjects: 76
Study 33461484 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 76
Study 35733201 — intervention group
Group type: EXPERIMENTAL
Intervention: CANreduce 2.0 with psychological support
Number of subjects: 0
Study 35733201 — intervention group
Group type: EXPERIMENTAL
Intervention: CANreduce 2.0 without psychological support
Number of subjects: 0
Study 35733201 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 0
Study 33256737 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-social condition
Number of subjects: 225
Study 33256737 — intervention group
Group type: EXPERIMENTAL
Intervention: Social condition
Number of subjects: 225
Study 33389304 — intervention group
Group type: EXPERIMENTAL
Intervention: Secret Agent Society (SAS)
Number of subjects: 70
Study 33389304 — intervention group
Group type: COMPARATOR
Intervention: Caregiver-supported cognitive skills training game (CIA)
Number of subjects: 70
Study 33210634 — intervention group
Group type: EXPERIMENTAL
Intervention: Social health insurance scheme awareness
Number of subjects: 385
Study 33210634 — intervention group
Group type: EXPERIMENTAL
Intervention: Social health insurance scheme importance
Number of subjects: 385
Study 33210634 — intervention group
Group type: EXPERIMENTAL
Intervention: Source of information
Number of subjects: 385
Study 33210634 — intervention group
Group type: EXPERIMENTAL
Intervention: Benefits of health insurance
Number of subjects: 385
Study 33210634 — intervention group
Group type: EXPERIMENTAL
Intervention: Future renewal of health insurance
Number of subjects: 385
Study 34877694 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous, cycling stimulation of CM-DBS for 3 months (blinded phase)
Number of subjects: 20
Study 34877694 — intervention group
Group type: COMPARATOR
Intervention: Control group (no stimulation)
Number of subjects: 20
Study 34877694 — intervention group
Group type: EXPERIMENTAL
Intervention: All patients (both groups)
Number of subjects: 20
Study 33298143 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefixime 400 mg orally twice a day for 10 days
Number of subjects: 0
Study 33298143 — intervention group
Group type: COMPARATOR
Intervention: Benzathine penicillin G 2.4 M IU intramuscularly once
Number of subjects: 0
Study 33547756 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital avoidance program
Number of subjects: 0
Study 33547756 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 32389377 — intervention group
Group type: EXPERIMENTAL
Intervention: Fully guided protocol with cylindrical guiding holes (12 implants)
Number of subjects: 12
Study 32389377 — intervention group
Group type: EXPERIMENTAL
Intervention: Fully guided protocol with C-shaped guiding holes (12 implants)
Number of subjects: 12
Study 32389377 — intervention group
Group type: COMPARATOR
Intervention: Partially guided protocol with cylindrical guiding holes (12 implants)
Number of subjects: 12
Study 32389377 — intervention group
Group type: COMPARATOR
Intervention: Partially guided protocol with C-shaped guiding holes (12 implants)
Number of subjects: 12
Study 33176084 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 3232
Study 33176084 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3232
Study 34059092 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-channel NMES
Number of subjects: 26
Study 34059092 — intervention group
Group type: COMPARATOR
Intervention: 2-channel NMES
Number of subjects: 26
Study 34059092 — intervention group
Group type: COMPARATOR
Intervention: Comparison of 4-channel NMES vs 2-channel NMES
Number of subjects: 26
Study 32883216 — intervention group
Group type: EXPERIMENTAL
Intervention: Selection Model (SM)
Number of subjects: 267
Study 32883216 — intervention group
Group type: EXPERIMENTAL
Intervention: Pattern-Mixture Model (PMM)
Number of subjects: 267
Study 32883216 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared-Parameters Model (SPM)
Number of subjects: 267
Study 32883216 — intervention group
Group type: EXPERIMENTAL
Intervention: Linear Mixed Models (LMM)
Number of subjects: 267
Study 33211352 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 0.5% timolol maleate (TM) applied to one cheek
Number of subjects: 25
Study 33211352 — intervention group
Group type: COMPARATOR
Intervention: Normal saline applied to the contralateral cheek (control)
Number of subjects: 25
Study 32678485 — intervention group
Group type: EXPERIMENTAL
Intervention: ENTRAMI technique (surgical release)
Number of subjects: 15
Study 35268024 — intervention group
Group type: EXPERIMENTAL
Intervention: Gummy L. plantarum Dad‐13 (108‐9 CFU/3 g) for 50 days
Number of subjects: 30
Study 35268024 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 50 days
Number of subjects: 30
Study 33040613 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 4742
Study 33040613 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4742
Study 32798463 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate stenting
Number of subjects: 305
Study 32798463 — intervention group
Group type: COMPARATOR
Intervention: Delayed stenting (after 24 to 48 hours with antithrombin therapy)
Number of subjects: 305
Study 36280151 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated hypofractionated radiotherapy (1.8 Gy daily to PTV with a 0.6 Gy boost to GTV, total 45 Gy to PTV and 60 Gy to GTV in 25 fractions over 5 weeks)
Number of subjects: 266
Study 36280151 — intervention group
Group type: COMPARATOR
Intervention: Conventional fractionated radiotherapy (2 Gy daily to PTV, total 44 Gy to PTV and 60 Gy to GTV in 30 fractions over 6 weeks)
Number of subjects: 266
Study 32779034 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel plus S-1 (DS)
Number of subjects: 61
Study 32779034 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin plus S-1 (CS)
Number of subjects: 61
Study 35596830 — intervention group
Group type: EXPERIMENTAL
Intervention: Pathways early autism intervention for children under 3 years
Number of subjects: 67
Study 35596830 — intervention group
Group type: EXPERIMENTAL
Intervention: Pathways early autism intervention for children over 3 years
Number of subjects: 67
Study 35596830 — intervention group
Group type: EXPERIMENTAL
Intervention: Pathways early autism intervention
Number of subjects: 67
Study 35596830 — intervention group
Group type: COMPARATOR
Intervention: Services-as-usual
Number of subjects: 67
Study 34407493 — intervention group
Group type: EXPERIMENTAL
Intervention: Online hazard perception training course
Number of subjects: 26
Study 34407493 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-supervisors observing the course
Number of subjects: 26
Study 34407493 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 26
Study 32162822 — intervention group
Group type: EXPERIMENTAL
Intervention: Talazoparib
Number of subjects: 412
Study 32162822 — intervention group
Group type: COMPARATOR
Intervention: Physician's choice of chemotherapy (PCT)
Number of subjects: 412
Study 35380740 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 5mg BID
Number of subjects: 1947
Study 35380740 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 10mg BID
Number of subjects: 1947
Study 33947729 — intervention group
Group type: EXPERIMENTAL
Intervention: Episodic adalimumab monotherapy (24 weeks)
Number of subjects: 0
Study 33947729 — intervention group
Group type: COMPARATOR
Intervention: Step-up care starting with corticosteroids
Number of subjects: 0
Study 32988625 — intervention group
Group type: EXPERIMENTAL
Intervention: Palonosetron-dexamethasone
Number of subjects: 64
Study 32988625 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron-dexamethasone
Number of subjects: 64
Study 35562806 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D print
Number of subjects: 25
Study 35562806 — intervention group
Group type: EXPERIMENTAL
Intervention: Head-mounted virtual reality headset
Number of subjects: 25
Study 35562806 — intervention group
Group type: EXPERIMENTAL
Intervention: Demonstration on a regular computer screen
Number of subjects: 25
Study 35562806 — intervention group
Group type: COMPARATOR
Intervention: Viewing the CT scan on a computer screen (gold standard)
Number of subjects: 25
Study 32423429 — intervention group
Group type: EXPERIMENTAL
Intervention: Onkyeong-tang (OKT), 3 g orally three times per day for 8 weeks
Number of subjects: 112
Study 32423429 — intervention group
Group type: COMPARATOR
Intervention: Placebo, 3 g orally three times per day for 8 weeks
Number of subjects: 112
Study 32423429 — intervention group
Group type: EXPERIMENTAL
Intervention: Onkyeong-tang (OKT)
Number of subjects: 112
Study 36495245 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined medical & mechanical method (trans-cervical foley catheter inflated with 60ml)
Number of subjects: 60
Study 36495245 — intervention group
Group type: COMPARATOR
Intervention: Medical method alone (mifepristone 200mg, followed by vaginal misoprostol 400μg every 4h)
Number of subjects: 60
Study 36495245 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined medical & mechanical method
Number of subjects: 60
Study 36495245 — intervention group
Group type: COMPARATOR
Intervention: Medical method alone
Number of subjects: 60